Statin Use in Nonalcoholic Fatty Liver Disease With Sertraline
Rosuvastatin is considered safe for patients with nonalcoholic fatty liver disease (NAFLD) across the disease spectrum, including advanced liver disease, when used with usual clinical monitoring. [1] Rosuvastatin can be used in patients taking sertraline, with no established need for dose adjustment based on a clinically important drug–drug interaction. [2], [3]
Rosuvastatin Safety in Nonalcoholic Fatty Liver Disease
Statins are considered safe in patients with NAFLD across the disease spectrum, including advanced liver disease. [1] The 2018 AASLD NAFLD practice guidance states that statins lead to a demonstrable reduction in cardiovascular morbidity and mortality. [1] Rosuvastatin labeling advises that liver enzyme elevations can occur and recommends liver enzyme testing before initiation and as clinically indicated thereafter. [4]
Drug–Drug Interaction Considerations With Sertraline
Rosuvastatin is a substrate of transporter systems including BCRP and OATP1B1. [3] Sertraline is listed as a weak CYP2D6 inhibitor and is not listed as a strong inhibitor of the transporter pathways highlighted for rosuvastatin exposure. [3] A clinical pharmacology review of SSRI–statin interactions concludes that rosuvastatin and pravastatin are likely to be safe in combination with SSRIs, including sertraline. [2]
Medication Selection Algorithm
For dyslipidemia in NAFLD, statin therapy is the preferred lipid-lowering strategy. [1]
Initiation Thresholds and Monitoring
Baseline and subsequent monitoring of liver enzymes is recommended based on rosuvastatin prescribing information. [4] Clinical monitoring should include assessment for statin-associated muscle symptoms and evaluation of contributing risk factors for myopathy. [4]
Treatment Goals
Statin therapy in NAFLD is used to reduce cardiovascular events by improving atherogenic lipid risk. [1]
Common Pitfalls to Avoid
Avoid initiating or continuing rosuvastatin without appropriate clinical monitoring for hepatic enzyme abnormalities given the known risk of liver enzyme elevations. [4] Avoid assuming NAFLD-related liver tests alone eliminate the need for standard statin safety monitoring. [1], [4]
Practical Safety Approach for the Combination
Rosuvastatin is appropriate in NAFLD while continuing sertraline when no other contraindications exist. [1], [2] If muscle symptoms or abnormal liver tests occur, temporary interruption and clinical evaluation should be performed in accordance with rosuvastatin safety guidance. [4]